Fig. 7. Potential mechanism underlying how the PRKD inhibitor CRT0066101 decreases breast cancer growth via blocking cell cycle progression at the G1 phase and increasing cell apoptosis.
Fig. 7. Potential mechanism underlying how the PRKD inhibitor CRT0066101 decreases breast cancer growth via blocking cell cycle progression at the G1 phase and increasing cell apoptosis.